Antonio Rivero‐Juárez

Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe

Antonio Rivero‐Juárez, Mario Frías, Ana Belén Pérez et al. · Journal of Hepatology · 2022 · 122 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde et al. · Clinical Infectious Diseases · 2017 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis

Nicolás Merchante, Antonio Rivero‐Juárez, Francisco Téllez et al. · Hepatology · 2012 · 88 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Familial Hepatitis E Outbreak Linked to Wild Boar Meat Consumption

Antonio Rivero‐Juárez, Mario Frías, Antonio Martínez-Peinado et al. · Zoonoses and Public Health · 2017 · 88 citations

Life Sciences, Infectious Diseases, Molecular Virology +14

Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis

José Antonio López Mira, Antonio Rivero‐Juárez, Luís F. López‐Cortés et al. · Clinical Infectious Diseases · 2013 · 82 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17